newsfilter
← Latest News
PR Newswire·

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug

Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products Diversifies Akanda into cancer pain medical market as a specialized manufacturer of cannabis-based drug